The US pathology laboratories market plays a critical role in the healthcare ecosystem by supporting disease diagnosis, treatment planning, and patient monitoring. Pathology laboratories serve as the foundation of modern healthcare, providing accurate diagnostic insights that help physicians make informed clinical decisions. As the burden of chronic diseases continues to rise and healthcare providers increasingly focus on early disease detection, the demand for pathology laboratory services is growing across the United States.
Advancements in laboratory technologies, digital pathology, molecular diagnostics, and precision medicine are reshaping the pathology landscape. Healthcare organizations are investing heavily in innovative diagnostic solutions that improve efficiency, accuracy, and patient outcomes, creating significant growth opportunities for the pathology laboratories market.
What is the US Pathology Laboratories Market Size?
The US pathology laboratories market size was calculated at USD 103.84 billion in 2025 and is predicted to increase from USD 112.33 billion in 2026 to approximately USD 229.75 billion by 2035, expanding at a CAGR of 7.42% from 2026 to 2035. The market is growing due to strategic partnerships between hospitals and laboratory service providers and growing demand for oncology, neurology, autoimmune disease, and women’s health testing.
Market Highlights
- By type, the hospital-based segment held the largest revenue share in 2025.
- By type, the diagnostic chains segment is expected to grow at a notable CAGR during the forecast period.
- By testing services, the clinical tests and general physiological segment held the major market share in 2025.
- By testing services, the esoteric tests segment is expected to grow at the highest CAGR between 2026 and 2035.
- By end-use, the physician referrals segment has contributed the highest revenue share in 2025.
- By end-use, the corporate segment is expected to register the fastest CAGR during the forecast period 2026 to 2035.
Market Overview
Pathology laboratories analyze biological samples such as blood, tissue, urine, and other bodily fluids to identify diseases and monitor treatment effectiveness. These laboratories support a wide range of medical specialties, including oncology, infectious diseases, cardiology, neurology, and genetics.
The increasing importance of laboratory testing in preventive healthcare and personalized medicine has elevated the role of pathology laboratories in modern healthcare delivery. With healthcare systems emphasizing early diagnosis and disease management, laboratory testing volumes continue to increase nationwide.
Key Factors Driving Market Growth
Rising Prevalence of Chronic Diseases
The growing incidence of cancer, diabetes, cardiovascular diseases, and other chronic conditions is driving demand for advanced pathology testing services. Early and accurate diagnosis is essential for improving patient outcomes and reducing healthcare costs.
Growing Adoption of Precision Medicine
Precision medicine relies heavily on pathology and molecular diagnostics to identify disease-specific biomarkers and tailor treatments to individual patients. As personalized healthcare becomes more widespread, pathology laboratories are becoming increasingly important.
Technological Advancements in Diagnostics
Innovations in digital pathology, artificial intelligence, molecular testing, next-generation sequencing, and automated laboratory systems are improving diagnostic accuracy and operational efficiency. These advancements are helping laboratories process larger testing volumes while maintaining high-quality standards.
Increasing Focus on Preventive Healthcare
Healthcare providers and patients are placing greater emphasis on preventive care and routine screening. This trend is increasing demand for laboratory testing services that help detect diseases at earlier stages.
Impact of Artificial Intelligence on the Market
Artificial intelligence is transforming pathology laboratories by enhancing diagnostic accuracy, improving workflow efficiency, and supporting faster clinical decision-making. AI-powered image analysis tools can assist pathologists in detecting abnormalities within tissue samples more efficiently.
Machine learning algorithms are helping laboratories analyze large datasets, identify disease patterns, and reduce diagnostic errors. AI integration also supports digital pathology platforms, enabling remote consultations and improving collaboration among healthcare professionals.
As healthcare organizations continue to adopt digital transformation strategies, AI is expected to become an integral component of pathology laboratory operations.
Emerging Market Trends
- Digital Pathology Adoption: Healthcare facilities are increasingly implementing digital pathology solutions that allow pathology slides to be scanned, stored, and analyzed electronically. Digital workflows improve efficiency and facilitate remote pathology services.
- Expansion of Molecular Diagnostics: Molecular testing is becoming an essential component of disease diagnosis and treatment selection. Laboratories are expanding their molecular diagnostic capabilities to meet growing demand for personalized medicine.
- Automation of Laboratory Workflows: Laboratories are investing in automated systems to streamline operations, improve turnaround times, and reduce manual errors. Automation is helping address workforce challenges while enhancing productivity.
- Growth of Telepathology Services: Telepathology enables pathologists to review and interpret diagnostic images remotely. The growing adoption of telemedicine is accelerating demand for remote pathology solutions.
Competitive Landscape
The market is highly competitive, with pathology laboratories focusing on technological innovation, service expansion, strategic partnerships, and laboratory automation. Companies are investing in digital pathology platforms, molecular testing services, and AI-powered diagnostic solutions to strengthen their market positions.
Leading market participants are also expanding their geographic reach and enhancing testing capabilities to meet the growing demand for specialized diagnostic services.
Pathology Laboratories Market Companies
- Unilab
- Falco Holdings
- Centro de Diagnósticos
- BioReference
- Healius Limited
- Kingmed Diagnostics
- Metropolis Healthcare
- Dr. Lal Path Labs
- Sonic Healthcare Limited
- SYNLAB International GmbH
- Spectra Laboratories
- Exact Sciences Laboratories LLC
- Laboratory Corporation of America Holdings
- Eurofins Scientific
- Quest Diagnostics Incorporated
Conclusion
The US pathology laboratories market is experiencing significant transformation as advancements in diagnostic technologies, artificial intelligence, and precision medicine reshape healthcare delivery. Rising chronic disease prevalence, increasing demand for early diagnosis, and growing adoption of personalized healthcare solutions are expected to drive continued market growth. As laboratories embrace digital innovation and automation, they will play an increasingly vital role in improving patient outcomes and advancing modern healthcare.
Get Our Sample Lnik : https://www.precedenceresearch.com/sample/8518
Recent Developments
- In January 2026, Alpenglow Biosciences and PathNet announced a strategic partnership to develop a national platform for 3D AI-powered cancer diagnostics. The collaboration will advance prostate and bladder cancer testing by integrating 3D pathology, volumetric imaging, AI analytics, and clinical validation into routine oncology workflows.
- In February 2026, Acupath Laboratories partnered with Azer Scientific to install the first AzerView digital pathology scanner in the United States. The milestone deployment is expected to improve image quality, diagnostic efficiency, and pathology workflow automation, supporting broader adoption of digital pathology technologies.
Segments Covered in the Report
By Type
- Diagnostic Chains
- Standalone Labs
- Hospital-Based
By Testing Service
- COVID-19 Tests
- Esoteric Tests
- Imaging & Radiology Tests
- Clinical Tests and General Physiological
By End-Use
- Corporate
- Walk-ins
- Physician Referrals
Also Read Our Latest Article : Cognitive Assessment and Brain Health Market
- Pharmacy Market Size to Surpass USD 1.99 Trillion by 2035 - July 9, 2026
- Bromelain Market Size to Attain USD 66.25 Billion by 2035 - July 9, 2026
- Biotechnology Instruments Market Size to Attain USD 133.49 Bn by 2035 - July 9, 2026